Exelixis (EXEL) stock analysis: 14x 2026E EPS vs. sector, cabozantinib growth, zanzalintinib upside, and FDA/Q4 catalysts.

C3.ai shows a Rule of -52.1% and high short interest with 2026 government shutdown risks and revenue divergence. Check out why AI stock is a hold.

Despite disruptions caused by a snowstorm, The Gray House in Springfield was able to provide food to families in need with ...

The company operates nearly 40 stores in rural Alaska. The new program is being tested at Alaska Commercial Company stores in ...

Ingersoll, Canada, population 13,000, relies heavily on the General Motors plant in town, and stands to lose much more if it ...

Imagion Biosystems, Singular Health Group and Lumos Diagnostics have been among ASX healthcare names reporting quarterly ...

Melania Trump's documentary is set to release on January 30, but the film has faced widespread vandalism in Los Angeles and ...

Even with a quarterback falling into their lap, the Pittsburgh Steelers go in a different direction in Daniel Jeremiah's ...

U.S. markets pointed slightly higher in premarket trading on mixed results from Big Tech, one day after the Federal Reserve’s ...

Plexus Corp (PLXS) reports a 10% revenue increase and secures significant new programs, despite facing sector-specific challenges and increased tax rates.

The report said Nvidia, an existing OpenAI partner whose chips support many AI workloads, is in talks to invest up to $30 ...

Baffinland Iron Mines says it can move forward with construction of the Steensby component of its Mary River iron ore mine on ...